Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
skin sensitisation: in vivo (LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2008
Report date:
2008

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Type of study:
mouse local lymph node assay (LLNA)

Test material

Constituent 1
Chemical structure
Reference substance name:
1-({[(2,5-dioxopyrrolidin-1-yl)oxy]carbonyl}oxy)ethyl 2-methylpropanoate
EC Number:
700-402-2
Cas Number:
860035-10-5
Molecular formula:
C11H15NO7
IUPAC Name:
1-({[(2,5-dioxopyrrolidin-1-yl)oxy]carbonyl}oxy)ethyl 2-methylpropanoate

In vivo test system

Test animals

Species:
mouse
Strain:
other: CBA/Ca
Sex:
female

Study design: in vivo (LLNA)

Vehicle:
dimethylformamide
Concentration:
50/50% w/w
No. of animals per dose:
4

Results and discussion

In vivo (LLNA)

Resultsopen allclose all
Parameter:
SI
Value:
ca. 19.01
Test group / Remarks:
10% w/w
Parameter:
SI
Value:
ca. 25.72
Test group / Remarks:
25% w/w
Parameter:
SI
Value:
ca. 23.32
Test group / Remarks:
50% w/w
Parameter:
other: disintegrations per minute (DPM)
Remarks on result:
other: Test 2: Vehicle; 5303.06 dpm 10% w/w: 100805.40dpm 25% w/w 136381.00dpm 50% w/w 123647.30

Applicant's summary and conclusion

Interpretation of results:
sensitising
Remarks:
Migrated information
Conclusions:
GSK1873183A produced a SI>3 at doses of 10, 25 and 50% w/w and is considered to be a skin senitiser under the conditions of the test.
Executive summary:

A study was performed to assess the skin sentitising potential of GSK1873183A in CBA.Ca strain mice following topical application to the dorsal surface of the ear. The method was designed to meet the requirements of OECD No 429 and Method B42 of Commission directive 2004/73/EC. Doses of 50mcl (25mcl per ear) of the test material in dimethylformamide were applied at concentrations of 10%, 25% and 50% w/w. The Stimulation Index expressed as radioactive incorporation was 19.01, 25.72 and 23.32 at the concentrations 10, 25 and 50% and the test material was considered to be a sensitiser under the conditions of the test.